Paying users zone. Data is hidden behind 
.
Get 1-month access to Allergan PLC for $15.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Allergan PLC (AGN)
Price to Operating Profit (P/OP)
since 2005
Beginner level
Calculation
Allergan PLC, P/OP, long-term trends, calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Operating income (loss)1 (in thousands) |
÷ | No. shares of common stock outstanding2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2017 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2016 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2015 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2014 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2013 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2012 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2011 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2010 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2009 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2008 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2007 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2006 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2005 | |
= | |
÷ | |
|
= | |
÷ | |
Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-28), 10-K (filing date: 2012-02-16), 10-K (filing date: 2011-02-22), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-23), 10-K (filing date: 2008-02-25), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-10).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Allergan PLC’s Annual Report.
Comparison to Competitors
Allergan PLC, P/OP, long-term trends, comparison to competitors
| Allergan PLC | Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Biogen Inc. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | |
|
|
|
|
|
|
|
| Dec 31, 2017 | |
|
|
|
|
|
|
|
| Dec 31, 2016 | |
|
|
|
|
|
|
|
| Dec 31, 2015 | |
|
|
|
|
|
|
|
| Dec 31, 2014 | |
|
|
|
|
|
|
|
| Dec 31, 2013 | |
|
|
|
|
|
|
|
| Dec 31, 2012 | |
|
|
|
|
|
|
|
| Dec 31, 2011 | |
|
|
|
|
|
|
|
| Dec 31, 2010 | |
|
|
|
|
|
|
|
| Dec 31, 2009 | |
|
|
|
|
|
|
|
| Dec 31, 2008 | |
|
|
|
|
|
|
|
| Dec 31, 2007 | |
|
|
|
|
|
|
|
| Dec 31, 2006 | |
|
|
|
|
|
|
|
| Dec 31, 2005 | |
|
|
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-28), 10-K (filing date: 2012-02-16), 10-K (filing date: 2011-02-22), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-23), 10-K (filing date: 2008-02-25), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-10).